Hudson-based medical technology firm Lifeward has hired a veteran finance and operations executive with medical device and public-company experience.
Get Instant Access to This Article
Subscribe to Worcester Business Journal and get immediate access to all of our subscriber-only content and much more.
Hudson-based medical technology firm Lifeward has hired a veteran finance and operations executive with medical device and public-company experience as its next CFO.
The company formerly known as ReWalk Robotics announced the hiring of Ronen Tsimerman via a filing with the U.S. Securities and Exchange Commission on Tuesday. Tsimerman comes to Lifeward following a nine-year stint at Israel-based IceCure Medical, where he served as CFO and chief operating officer. Tsimerman will begin his role as Lifeward’s CFO on Nov. 1.Â
Tsimerman’s hiring comes as Lifeward announced the departure of CFO Almog Adar on Aug. 14, effective Sep. 30. Former Lifeward CEO Mark Grant left the company in September, as the firm has dealt with recent widening losses and a cash crunch.
Lifeward’s Form 10-Q filing detailing its second-quarter results included a going concern disclosure about the company’s existing cash resources, saying its $9.4 million in cash and cash equivalents as of June 30 were not sufficient to fund planned operations for the following 12 months.
Prior to IceCure, Tsimerman previously served in stints as CFO of Insuline Medical and Mer-Group. Both firms are based in Israel.Â
He holds a bachelor’s degree in business and an MBA from The College of Management Academic Studies in Israel.
Lifeward has its U.S. operations based at 2 Cabot Road in Hudson. The company moved its U.S. headquarters from Marlborough after announcing in 2024 it was streamlining its operations and reducing its real estate footprint.
Eric Casey is the managing editor at Worcester Business Journal, and primarily covers the real estate and banking & finance industries.